VIDEO: Visual acuity gains demonstrated in PEACHTREE trial

VANCOUVER, British Columbia — Steven Yeh, MD, describes efficacy and safety findings from the PEACHTREE trial, which he presented at the American Society of Retina Specialists annual meeting. Patients who received suprachoroidal CLS-TA (Clearside Biomedical) for macular edema due to noninfectious uveitis achieved clinically meaningful visual acuity improvement at week 24 after two injections, one at baseline and one at week 12.

Full Story →